
The future of a widely used abortion drug at the centre of the nation’s biggest legal battle over abortion rights since the end of Roe v Wade could be in the hands of the US Supreme Court.
Justices on the nation’s highest court will weigh in on a case targeting the federal government’s 23-year-old approval of mifepristone, part of a two-drug protocol for medication abortion, the most common form of abortion in the US.